Mulligan Mobilization vs Shockwave Therapy in Adhesive Capsulitis

NCT ID: NCT07310810

Last Updated: 2025-12-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-01

Study Completion Date

2026-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To investigate and compare the effects of Mulligan mobilization versus shock wave therapy in patients with adhesive capsulitis on Pain intensity level, Range of motion, Functional disability level, Ultrasonographic changes (soft tissue thickness) and Hand grip strength.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

sixty patients of both genders according to sample size calculation, referred from orthopedist, diagnosed adhesive capsulitis patients. they screened according to inclusion and exclusion criteria. Their age between 40 and 60 years was randomly allocated to three treatment groups.

* Group A (study group) (n=20) will receive mulligan technique and conventional treatment.
* Group B (study group) (n=20) will receive extracorporeal shockwave therapy and conventional treatment.
* Group C (control group) (n=20) will receive conventional treatment only.

Inclusion criteria: patients that will be included in the study will be referred from orthopedic physician with:

1. Patients referred from orthopedist and diagnosed as frozen shoulder
2. The age of the participant will be from 40-60 (Agarwal S., et al.2016).
3. Body mass index from 25- 30 kg/m2.
4. having a painful stiff shoulder for at least 3 months
5. having limited ROM of a shoulder joint (ROM losses of 25% or greater compared with the noninvolved shoulder in at least 2 of the following shoulder motions: glenohumeral flexion, abduction and lateral rotation.
6. ability to complete Disabilities of the Arm, Shoulder and Hand questionnaires (DASH).

Exclusion criteria:

1. history of surgery on the particular shoulder
2. Rheumatoid arthritis
3. painful stiff shoulder after a severe trauma
4. fracture of the shoulder complex
5. rotator cuff rupture
6. tendon calcification.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adhesive Capsulitis

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Adhesive capsulitis Mulligan mobilization EXTRACORPOREAL SHOCKWAVE THERAPY ULTRASONOGRAPHIC CHANGES

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

- Group A (study group)

received mulligan technique and conventional treatment

Group Type EXPERIMENTAL

Mulligan mobilization

Intervention Type OTHER

Mobilization with movement (MWM) is the concurrent application of sustained accessory mobilization applied by a therapist and an active physiological movement to end range applied by the patient. Passive end-of-range overpressure, or stretching, is then delivered without pain as a barrier

Conventional treatment

Intervention Type OTHER

Conventional treatment will be axillary ultrasound and laser ,low loading stretching exercise and home program exercises

Group B (study group)

received extracorporeal shockwave therapy and conventional treatment.

Group Type EXPERIMENTAL

Shockwave

Intervention Type DEVICE

From sitting with shoulder abducted at 45 degree and elbow flexed and the forearm rested on flat surface, The patients in the intervention group B received shock wave therapy once a week for 4 weeks. The focus probe sets were used and, in each session, patients received ESWT from anterior and posterior directions (on the average 1200 shocks between 0.1 and 0.3 mJ/mm2) up to the maximum threshold of pain tolerance in the shoulder

Conventional treatment

Intervention Type OTHER

Conventional treatment will be axillary ultrasound and laser ,low loading stretching exercise and home program exercises

Group C (control group)

received conventional treatment only.

Group Type EXPERIMENTAL

Conventional treatment

Intervention Type OTHER

Conventional treatment will be axillary ultrasound and laser ,low loading stretching exercise and home program exercises

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Shockwave

From sitting with shoulder abducted at 45 degree and elbow flexed and the forearm rested on flat surface, The patients in the intervention group B received shock wave therapy once a week for 4 weeks. The focus probe sets were used and, in each session, patients received ESWT from anterior and posterior directions (on the average 1200 shocks between 0.1 and 0.3 mJ/mm2) up to the maximum threshold of pain tolerance in the shoulder

Intervention Type DEVICE

Mulligan mobilization

Mobilization with movement (MWM) is the concurrent application of sustained accessory mobilization applied by a therapist and an active physiological movement to end range applied by the patient. Passive end-of-range overpressure, or stretching, is then delivered without pain as a barrier

Intervention Type OTHER

Conventional treatment

Conventional treatment will be axillary ultrasound and laser ,low loading stretching exercise and home program exercises

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Mobilization with movement

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients referred from orthopedist and diagnosed as frozen shoulder The age of the participant will be from 40-60 (Agarwal S., et al.2016). Body mass index from 25- 30 kg/m2. having a painful stiff shoulder for at least 3 months having limited ROM of a shoulder joint (ROM losses of 25% or greater compared with the noninvolved shoulder in at least 2 of the following shoulder motions: glenohumeral flexion, abduction and lateral rotation.

ability to complete Disabilities of the Arm, Shoulder and Hand questionnaires (DASH).

Exclusion Criteria

history of surgery on the particular shoulder Rheumatoid arthritis painful stiff shoulder after a severe trauma fracture of the shoulder complex rotator cuff rupture tendon calcification.
Minimum Eligible Age

40 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mohamed Ragab Gaber

lecturer assistant

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mohamed R Gaber, Asst. lect.

Role: PRINCIPAL_INVESTIGATOR

Cairo University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Physical Therapy

Giza, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

012/005863

Identifier Type: -

Identifier Source: org_study_id